News
-
-
-
PRESS RELEASE
APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
APONTIS PHARMA AG waives minimum acceptance condition in Zentiva's public purchase offer. Around 60% shares tendered. Management recommends acceptance. Cash consideration offers premium -
-
-
-
PRESS RELEASE
EV Nickel Reports Precious Metals Assays Associated with Elevated Nickel Mineralization in Hole Ev24-Car08 on the CarLang C Zone
EV Nickel Inc. announces significant nickel mineralization with high PGM values in CarLang C area, indicating potential for magmatic sulphide source. Exploration and testing programs ongoing -
-
-
PRESS RELEASE
APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted
APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024, with revenue guidance adjusted. Novartis collaboration boosts revenues. Full-year forecast slightly lowered